In vivo anti-tumor activity of photodynamic therapy with intravenous administration of acridine orange, followed by illumination with high-power flash wave light in a mouse osteosarcoma model

  • Authors:
    • Haruhiko Satonaka
    • Katsuyuki Kusuzaki
    • Takao Matsubara
    • Ken Shintani
    • Tomoki Nakamura
    • Akihiko Matsumine
    • Takahiro Iino
    • Atsumasa Uchida
  • View Affiliations

  • Published online on: January 1, 2010     https://doi.org/10.3892/ol_00000012
  • Pages: 69-72
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

In a recent study, we demonstrated that a high-power flash wave light (FWL) from a xenon lamp exerted a stronger cytocidal effect against a mouse osteosarcoma cell line than continuous wave light (CWL) in photodynamic therapy with acridine orange (AO-PDT). Based on our in vitro results, we investigated the in vivo anti-tumor activity of AO-PDT using flash wave light from a xenon lamp in a mouse osteosarcoma model. Mouse osteosarcoma cells (LM8) were injected into the subcutaneous tissue of the back of C3H mice, and tumors that grew to approximately 3 mm in diameter were treated by AO-PDT using FWL. AO was administered by intravenous injection and 2 h later the entire body of the mouse was illuminated with FWL from a xenon lamp. Significant growth inhibition of the tumor xenografts was observed as compared with that in the control group, suggesting that AO-PDT with FWL may be useful in the treatment of osteosarcoma. An immunohistochemical study of the tumors treated by AO-PDT showed that the underlying mechanism of the tumor growth inhibition involved both apoptosis and necrosis. In conclusion, it appears that following the intravenous administration of AO, AO-PDT in combination with FWL exerts strong anti-tumor activity. Inhibitory effects against growth of the primary tumor in human patients with osteosarcoma as well as other musculoskeletal sarcomas were also observed.
View Figures
View References

Related Articles

Journal Cover

January-February 2010
Volume 1 Issue 1

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Satonaka H, Kusuzaki K, Matsubara T, Shintani K, Nakamura T, Matsumine A, Iino T and Uchida A: In vivo anti-tumor activity of photodynamic therapy with intravenous administration of acridine orange, followed by illumination with high-power flash wave light in a mouse osteosarcoma model . Oncol Lett 1: 69-72, 2010.
APA
Satonaka, H., Kusuzaki, K., Matsubara, T., Shintani, K., Nakamura, T., Matsumine, A. ... Uchida, A. (2010). In vivo anti-tumor activity of photodynamic therapy with intravenous administration of acridine orange, followed by illumination with high-power flash wave light in a mouse osteosarcoma model . Oncology Letters, 1, 69-72. https://doi.org/10.3892/ol_00000012
MLA
Satonaka, H., Kusuzaki, K., Matsubara, T., Shintani, K., Nakamura, T., Matsumine, A., Iino, T., Uchida, A."In vivo anti-tumor activity of photodynamic therapy with intravenous administration of acridine orange, followed by illumination with high-power flash wave light in a mouse osteosarcoma model ". Oncology Letters 1.1 (2010): 69-72.
Chicago
Satonaka, H., Kusuzaki, K., Matsubara, T., Shintani, K., Nakamura, T., Matsumine, A., Iino, T., Uchida, A."In vivo anti-tumor activity of photodynamic therapy with intravenous administration of acridine orange, followed by illumination with high-power flash wave light in a mouse osteosarcoma model ". Oncology Letters 1, no. 1 (2010): 69-72. https://doi.org/10.3892/ol_00000012